¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"marker trait"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • autosomal dominant trait
    º¸Åë¿°»öü¿ì¼º¼ÒÁú, »ó¿°»öü¿ì¼º¼ÒÁú
  • autosomal recessive trait
    º¸Åë¿°»öü¿­¼º¼ÒÁú, »ó¿°»öü¿­¼º¼ÒÁú
  • dominant trait
    ¿ì¼º¼ÒÁú
  • intermediate trait
    Áß°£¼ºÇâ(¼ÒÁú)
  • multifactorial trait
    ´ÙÀÎÀÚ¼ÒÁú
  • recessive trait
    ¿­¼º¼ÒÁú
  • sickle cell trait
    ³´ÀûÇ÷±¸¼ÒÁú, ³´¼¼Æ÷¼ºÇâ
  • allotypic marker
    µ¿Á¾Ç׿øÇ¥ÁöÀÚ
  • biological marker
    »ý¹°ÇÐÀûÇ¥ÁöÀÚ
  • DNA marker
    DNAÇ¥ÁöÀÚ
  • molecular marker
    ºÐÀÚÇ¥ÁöÀÚ
  • marker
    1. Ç¥ÁöÀÚ 2. Ç¥Áö
  • marker gene
    Ç¥ÁöÀ¯ÀüÀÚ
  • marker rescue
    Ç¥Áö±¸Á¶
  • microbiologic marker
    ¹Ì»ý¹°Ç¥ÁöÀÚ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • marker
    Ç¥Áö, Ç¥ÁöÀÚ
  • biological marker
    »ý¹°ÇÐÀûÇ¥Áö
  • tumor marker
    Á¾¾çÇ¥ÁöÀÚ
  • triple marker test
    »ïÁßÇ¥Áö°Ë»ç
  • trait
    ¼ÒÁú, ¼ºÇâ
  • autosomal dominant trait
    º¸Åë¿°»öü¿ì¼º¼ÒÁú
  • autosomal recessive trait
    º¸Åë¿°»öü¿­¼º¼ÒÁú
  • sex-linked trait
    ¼º¿¬°ü¼ÒÁú, ¹Ý¼º¼ÒÁú
  • sickle cell trait
    ³´¼¼Æ÷¼ÒÁú, ³´ÀûÇ÷±¸Çü¼º¼ÒÁú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • autosomal dominant trait
    º¸Åë¿°»öü¿ì¼º¼ÒÁú
  • autosomal recessive trait
    º¸Åë¿°»öü¿­¼º¼ÒÁú
  • dominant trait
    ¿ì¼º¼ÒÁú
  • hereditary trait
    À¯Àü¼ÒÁú
  • multifactorial trait
    ´ÙÀÎÀÚ¼ºÇâ
  • recessive trait
    ¿­¼º¼ÒÁú
  • sex-linked trait
    ¹Ý¼º¼ÒÁú, ¼º¿¬°á¼ÒÁú
  • sickle cell trait
    ³´¼¼Æ÷¼ÒÁú, ³´ÀûÇ÷±¸Çü¼º¼ÒÁú
  • trait
    ¼ÒÁú, ¼ºÇâ
  • allotypic marker
    À¯ÀüÀûÇ¥Áö
  • biological marker
    »ý¹°ÇÐÀûÁöÇ¥
  • marker gene
    Ç¥ÁöÀ¯ÀüÀÚ
  • marker
    Ç¥Áö, Ç¥ÁöÀÚ
  • marker rescue
    Ç¥Áö±¸Á¶
  • microbiologic marker
    ¹Ì»ý¹°ÇÐÀûÇ¥ÁöÀÚ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Lyt marker
    LytÇ¥Áö
  • allotypic marker
    À¯ÀüÀû Ç¥Áö(ë¶îîîÜøöãÛ).
  • anatomical marker
    ÇØºÎÇÐÀûÇ¥Áö
  • genetic marker
    À¯Àü¼º Ç¥Áö
  • genetic marker
    À¯ÀüÇ¥Áö(¡­øöãÛ).
  • genetic marker
    À¯Àü[Àû]Ç¥Áö
  • genetic marker
    À¯Àü[Àû]Ç¥Áö
  • genetic marker
    À¯ÀüÇ¥ÁöÇüÁú.
  • Cooleys trait=thalassemia minor
    Äí¿ï¸®¼ÒÁú(áÈòõ)= °æÁõ¼º ÁöÁßÇØºóÇ÷
  • Hageman trait
    ÇϰԸ¸ÇüÁú
  • alpha-thalassemia trait
    ¾ËÆÄ-Å»¶ó¼¼¹Ì¾Æ ¼ÒÀÎ
  • hemoglobin C trait
    CÇü ¼ÒÁú<Ư¼º
  • hemoglobin D trait
    Çì¸ð±Û·ÎÁø D ¼ÒÁú<Ư¼º
  • hemoglobin E trait
    Çì¸ð±Û·Îºó E ¼ÒÁú<Ư¼º
  • hereditary trait
    À¯Àü¼ÒÁú(ë¶îîáÈòõ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • allotypic marker
    À¯ÀüÀû Ç¥Áö(ë¶îîîÜøöãÛ).
  • anatomical marker
    ÇØºÎÇÐÀûÇ¥Áö
  • biological marker
    »ý¹°ÇÐÀû Ç¥Áö(ÀÚ)
  • genetic marker
    À¯ÀüÇ¥ÁöÇüÁú.
  • genetic marker
    À¯ÀüÇ¥Áö(¡­øöãÛ).
  • genetic marker
    À¯Àü[Àû]Ç¥Áö
  • genetic marker
    À¯Àü[Àû]Ç¥Áö
  • genetic marker
    À¯Àü¼º Ç¥Áö
  • marker
    Ç¥Áö(ÀÚ)
  • marker gene
    Ç¥ÁöÀ¯ÀüÀÚ(øöãÛë¶îîí­).
  • marker rescue
    Ç¥Áö±¸Á¶
  • marker rescuemature virus
    Ç¥Áö ±¸Á¶
  • microbiologic marker
    ¹Ì»ý¹°ÇÐÀû Ç¥ÁöÀÚ
  • molecular marker
    ºÐÀÚÇ¥Áö(ÀÚ)
  • surface marker
    Ç¥¸éÇ¥Áö(ÀÚ)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sickle cell trait
    ³´¼¼Æ÷(á¬øà)¼ºÇâ(àõú¾)
  • biochemical marker
    »ýÈ­ÇÐÀû(ßæûùùÊîÜ) Ç¥ÁöÀÚ(øöò½í­)
  • counterselective marker
    ¿ª¼±Åà ǥÁöÀÚ(æ½àÔ÷Éøöò½íº)
  • genetic marker
    À¯Àü Ç¥ÁöÇüÁú (ë¶îîøöò½û¡òõ)
  • idiotypic marker
    °³Ã¼Æ¯ÀÌÇü(ËÁô÷÷åì¶úþ) Ç¥ÁöÀÚ(øöò½í­)
  • in vitro marker
    ½ÃÇè°ü³» Ç¥Áö(ãËúÐηҮøöò½)
  • in vivo marker
    »ýü³» Ç¥Áö(ßæô÷Ò®øöò½)
  • marker
    Ç¥ÁöÀÚ(øöò½í­)
  • marker enzyme
    Ç¥ÁöÈ¿¼Ò(øöò½ý£áÈ)
  • marker rescue
    Ç¥ÁöÀÚ ±¸Á¶(øöò½í­Ï­ð¾)
  • Marker synthesis
    ¸¶Ä« ÇÕ¼º(ùêà÷)
  • selected marker
    ¼±ÅÃÇ¥Áö(àÔ÷Éøöò½)
  • selective marker
    ¼±Åüº Ç¥Áö(àÔ÷Éàõøöò½)
  • self-marker theory
    ÀÚ±â Ç¥Áö ÀÌ·Ð(í»Ðùøöò½×âÖå)
  • unselective marker
    ºñ¼±ÅÃ(ÞªàÔ÷É) Ç¥ÁöÀÚ(øöò½í­)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • marker
    Ç¥Áö(ÀÚ)
  • trait
    Ư¼º, ¼ÒÁú, üÁú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MEN Multiple Endocrine Neoplasia
  ; AD Trait
  1. MEN Type I(= Wermer Syndro...
PBT Paul-Bunnell test; phenacetin breath test; piebald trait; profile-based therapy
PTD percutaneous transluminal dilatation; permanent total disability; personality trait disorder; preter...
SCT secretin; sex chromatin test; sexual compatibility test; sickle-cell trait; sperm cytotoxicity; spin...
STAI State Trait Anxiety Inventory
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MAS Marker Assisted Selection
OMP Olfactory Marker Protein
SMP 30 Senescence marker protein 30
SMC Supernumerary Marker Chromosome
Lin lineage marker
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cell surface marker
    ¼¼Æ÷ Ç¥¸é Ç¥ÁöÀÚ
  • enzyme marker study
    È¿¼Ò Ç¥Áö ¿¬±¸
  • marker gene
    Ç¥Áö À¯ÀüÀÚ
  • autosomal dominant trait
    »ó¿°»öü ¿ì¼º À¯Àü ÇüÁú
  • dominant trait
    ¿ì¼º ¼ÒÁú
  • pedigree pattern of autosomal dominant trait
    »ó¿°»öü¼º ¿ì¼º ÇüÁúÀÇ °¡°èµµ
  • qnantitative trait
    ÇüÁú
  • recessive trait
    ¿­¼º ÇüÁú
  • sex linked trait
    ¹Ý¼º ÇüÁú
  • sickle cell trait
    °â»ó ÀûÇ÷±¸ ¼ÒÁú
    »ê¼Ò ºÐ¾ÐÀÌ ³·Àºµ¥¼­ Æø·ÎµÈ ¶§ ÀûÇ÷±¸ÀÇ °â»óÈ­·Î ÀνĵǴ »ç¶÷ÀÇ »óÅÂ. °â»ó ÀûÇ÷±¸ ºóÇ÷°ú °ü°è°¡ ÀÖ´Â ´ë¸³À¯ÀüÀÚÀÇ ÇìÅ×·Î Á¢ÇÕ¿¡ ±âÀÎÇÑ´Ù.
  • sickle-cell trait
    ÀûÇ÷±¸ °â»óÇü¼º °æÇâ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
marker trait A trait that may be of little importance in itself but which by association, linkage, or other means facilitates the detection, anticipation, or understanding of a disease or (for genetic diseases) the localization of the causative gene on the karyotype.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
allotypic marker Synonym: allotype.
(05 Mar 2000)
Bombay trait A rare recessive trait at a locus that ordinarily manufactures H substance, the precursor from which the A and B phenotypes are elaborated; the mutant causes failure to produce H substance and no matter what the genotype at the ABO locus, the phenotype is O. The Bombay phenomenon is epistatic to the ABO locus.
Origin: Bombay, India, where first reported
(05 Mar 2000)
galtonian trait A quantitative genetic trait due to contributions from many more of less equally important loci that resembles a continuous trait.
(05 Mar 2000)
genetic marker A gene which has an easily identifiable phenotype so that one can tell apart cells or individuals which have the gene and those which do not have it. Such a gene can also be used as a probe to mark cell nuclei or chromosomes so that they can easily be isolated or identified from other nuclei or chromosomes later.
(09 Oct 1997)
recessive trait See: dominance of traits.
(05 Mar 2000)
marker An identifiable physical location on a chromosome (for example, restriction enzyme cuttingsite, gene) whose inheritance can bemonitored. Markers can beexpressed regions of DNA (genes) or some segment of DNA with no knowncoding function but whose pattern of inheritance can be determined.
See: restriction fragment length polymorphism.
(09 Oct 1997)
marker chromosome An abnormal chromosome that is distinctive in appearance but not fully identified. For example, the fragile x chromosome was once called the marker x.
(12 Dec 1998)
marker enzyme <enzyme> An enzyme that is used to identify a specific cell type, cell organelle, or cell component.
(05 Mar 2000)
marker gene Gene that confers some readily detectable phenotype on cells carrying the gene, either in culture or in transgenic or chimeric organisms. Gene could be an enzymic reporter gene, a selectable marker conferring antibiotic resistance or a cell membrane protein with a characteristic epitope.
(18 Nov 1997)
marker locus A locus on a chromosome or in a stretch of DNA that can be identified (e.g., a restriction fragment length polymorphism) and can serve in linkage analysis and in the isolation of a disease gene.
See: linkage marker.
(05 Mar 2000)
marker, object <microscopy> A small abrasive stylus, set in a rotating holder mounted on the lower end of the drawtube. The desired part of the specimen is placed in the centre of the field, and the abrasive point is pressed against the slide or cover, and rotated. It describes a tiny circle around the desired object field.
(05 Aug 1998)
categorical trait <genetics> A feature that can conveniently and effectively be analyzed by sorting into classes either because there is no satisfactory way of measuring it (as with blood groups) or because it falls into natural classes so that the variation among classes far exceeds that within classes (e.g., the phenotypic effects of many enzyme polymorphisms); existence of categories suggests but does not prove the operation of a major, simple, underlying cause.
Synonym: qualitative trait.
(05 Mar 2000)
cell marker <cell biology> Biochemical or genetic characteristics which distinguish and discriminate between different cell types.
(26 Mar 1998)
cell surface marker <cell biology> Any molecule characteristic of the plasma membrane of a cell or in some cases of a specific cell type. 5' nucleotidase and Na/K ATPase are often used as plasma membrane markers.
(26 Mar 1998)
penetrant trait A trait that in the appropriate genotypes is phenotypically manifest; strictly, it is the trait that is penetrant, not the gene.
See: penetrance.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • trait
    Ư¡, Ư¼º
  • culture trait
    ¹®È­Àû Ư¼º
  • trait
    Ư»ö;Ư¡;¾ó±¼ ¸ð½À
  • marker
    Ç¥¸¦ ÇÏ´Â »ç¶÷
  • Magic Marker
    ¸ÅÁ÷Ææ (»óÇ¥¸í)
  • endoftape marker
    (ÀüÀÚ)Å×ÀÌÇÁÀÇ ³¡ Ç¥½Ã¹°(ÀÚ±â Å×ÀÌÇÁÀÇ ³¡À» ³ªÅ¸³»´Â Ç¥½Ã)
  • fan marker
    ºÎä²Ã À§Ä¡ Ç¥Áö(°øÇ× ºÎ±Ù¿¡ ¹èÄ¡µÇ¾î ÀüÆÄ·Î ºñÇà±â¸¦ À¯µµÇÔ)
  • fan marker
    ºÎä²Ã À§Ä¡Ç¥Áö
  • ground marker
    Á¶¸íź(¸ñÇ¥ Áö¿ªÀ» ºñÃß±â À§ÇØ ³«ÇÏ»ê ¾øÀÌ ¶³¾î¶ß¸®´Â)
  • image marker
    0m'eik5~r;À̹ÌÁö¸¦ ¸¸µå´Â »ç¶÷;±¤°íÀÎ
  • inner marker beacon
    (°ø)°è±â Âø·úÀåÄ¡ÀÇ ÀϺÎ
  • marker
    (°ÔÀÓÀÇ) µæÁ¡ ±â·Ï¿ø(ÀåÄ¡);¼­Ç¥;¹¦ºñ;ÀÌÁ¤Ç¥;Á¶¸íź
  • marker crude
    ±âÁØ ¿øÀ¯
  • marker price
    ±âÁØ °¡°Ý
  • mile marker
    ÁÖ°£ °£¼± µµ·Îº¯¿¡ ÀÖ´Â ¹øÈ£°¡ ºÙÀº ¸¶ÀÏ Ç¥Áö
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á